Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo-controlled randomized trial

Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo-controlled randomized trial

Treating Veterans with chronic obstructive pulmonary disease complicated by pulmonary hypertension (COPD-PH) using phosphodiesterase type-5 inhibitor pharmacotherapy is common, but efficacy data are lacking. To address this further, patients with COPD-PH from five Department of Veterans Affairs hosp...

Full description

Bibliographic Details
Main Authors: Choudhary, G. (Author), Dempsey, E.C (Author), Garshick, E. (Author), Goldstein, R.H (Author), Goldstein, R.L (Author), Hattler, B. (Author), Jankowich, M. (Author), LaCerda, K.A (Author), Maron, B.A (Author), Rounds, S.I (Author), Sadikot, R.T (Author), Shapiro, S. (Author), Tucker, T.J.S (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2022
Subjects:
exercise capacity
lung disease
pulmonary vascular disease
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items